Advisor Group Holdings, Inc. Vigil Neuroscience, Inc. Transaction History
Advisor Group Holdings, Inc.
- $67.1 Billion
- Q3 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 565 shares of VIGL stock, worth $4,548. This represents 0.0% of its overall portfolio holdings.
Number of Shares
565
Previous 565
-0.0%
Holding current value
$4,548
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VIGL
# of Institutions
6Shares Held
4.69MCall Options Held
0Put Options Held
0-
Northpond Ventures, LLC4.21MShares$33.9 Million51.65% of portfolio
-
Black Rock Inc. New York, NY405KShares$3.26 Million0.0% of portfolio
-
Peak6 Investments LLC Chicago, IL41.5KShares$333,9620.0% of portfolio
-
Xtx Topco LTD London, X026.3KShares$211,6980.01% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$0100.0% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $228M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...